Medtronic (MDT) shares dipped 0.7% in Tuesday's late trading session. The decline followed the company's announcement of a strategic collaboration agreement with brain-computer interface startup Precision Neuroscience. The partnership aims to integrate Precision's flexible thin-film brain-computer interface, known as Layer 7, with Medtronic's StealthStation surgical navigation system. Together, they will co-develop an intraoperative solution that enables "synchronized structural-functional visualization."
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments